Perspective Therapeutics (CATX) Current Assets (2011 - 2026)
Perspective Therapeutics recorded quarterly Current Assets of $275.4 million in Q1 2026, up 85.56% quarter-over-quarter from $148.4 million in Q4 2025, and up 27.63% year-over-year from $215.7 million in Q1 2025.
Perspective Therapeutics' Current Assets history runs 16 years deep, the most recent figure standing at $275.4 million for Q1 2026.
- In Q1 2026, Current Assets rose 27.63% year-over-year to $275.4 million; the TTM figure through Mar 2026 stood at $275.4 million (up 27.63% YoY), while the FY2025 annual figure was $148.4 million, down 35.81% from the prior year.
- Current Assets came in at $275.4 million for Q1 2026 at Perspective Therapeutics, up from $148.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $294.2 million in Q2 2024 to a low of $16.8 million in Q4 2023.
- A 5-year average of $137.7 million and a median of $148.4 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets tumbled 68.36% in 2023 and jumped 1272.93% in 2024, its largest moves.
- Perspective Therapeutics' Current Assets stood at $53.2 million in 2022, then sank by 68.36% to $16.8 million in 2023, then surged by 1272.93% to $231.2 million in 2024, then sank by 35.81% to $148.4 million in 2025, then surged by 85.56% to $275.4 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $275.4 million, $148.4 million, and $178.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.45 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 4.33 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.39 Bn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 275.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 275.35 Mn |
| Dec 31, 2025 | 148.39 Mn |
| Sep 30, 2025 | 178.50 Mn |
| Jun 30, 2025 | 195.96 Mn |
| Mar 31, 2025 | 215.74 Mn |
| Dec 31, 2024 | 231.16 Mn |
| Sep 30, 2024 | 270.17 Mn |
| Jun 30, 2024 | 294.24 Mn |
| Mar 31, 2024 | 188.20 Mn |
| Dec 31, 2023 | 16.84 Mn |
| Sep 30, 2023 | 21.69 Mn |
| Jun 30, 2023 | 31.95 Mn |
| Mar 31, 2023 | 40.27 Mn |
| Dec 31, 2022 | 53.22 Mn |
| Sep 30, 2022 | 57.54 Mn |
| Jun 30, 2022 | 59.33 Mn |
| Mar 31, 2022 | 62.76 Mn |
| Dec 31, 2021 | 63.60 Mn |
| Sep 30, 2021 | 64.96 Mn |
| Jun 30, 2021 | 67.30 Mn |
| Mar 31, 2021 | 68.07 Mn |
| Dec 31, 2020 | 12.29 Mn |
| Sep 30, 2020 | 4.75 Mn |
| Jun 30, 2020 | 5.51 Mn |
| Mar 31, 2020 | 5.72 Mn |
| Dec 31, 2019 | 5.63 Mn |
| Sep 30, 2019 | 6.81 Mn |
| Jun 30, 2019 | 7.32 Mn |
| Mar 31, 2019 | 8.43 Mn |
| Dec 31, 2018 | 9.82 Mn |
| Sep 30, 2018 | 11.27 Mn |
| Jun 30, 2018 | 5.45 Mn |
| Mar 31, 2018 | 6.33 Mn |
| Dec 31, 2017 | 7.42 Mn |
| Sep 30, 2017 | 8.87 Mn |
| Jun 30, 2017 | 10.29 Mn |
| Mar 31, 2017 | 11.92 Mn |
| Dec 31, 2016 | 13.18 Mn |
| Sep 30, 2016 | 14.93 Mn |
| Jun 30, 2016 | 13.63 Mn |
| Mar 31, 2016 | 13.24 Mn |
| Dec 31, 2015 | 14.28 Mn |
| Jun 30, 2015 | 16.33 Mn |
| Jun 30, 2014 | 19.21 Mn |
| Mar 31, 2014 | 25.11 Mn |
| Dec 31, 2013 | 5.92 Mn |
| Sep 30, 2013 | 6.90 Mn |
| Jun 30, 2013 | 4.44 Mn |
| Mar 31, 2013 | 5.09 Mn |
| Dec 31, 2012 | 5.74 Mn |
| Sep 30, 2012 | 6.50 Mn |
| Jun 30, 2012 | 4.14 Mn |
| Mar 31, 2012 | 4.01 Mn |
| Dec 31, 2011 | 5.16 Mn |
| Sep 30, 2011 | 3.56 Mn |
| Jun 30, 2011 | 4.22 Mn |